Navigation Links
Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning
Date:5/29/2008

- State officials desire quick-response emergency capability to treat

suspected and known cyanide poisoning -

NAPA, Calif., May 29 /PRNewswire/ -- Dey, L.P. today announced that the Florida Department of Health, Office of Emergency Operations, will stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE for Cyanide Poisoning in the State's emergency medical service (EMS) and fire vehicles through a federal grant from the Department of Homeland Security. As the only FDA-approved treatment that can be given to victims of suspected cyanide poisoning, Cyanokit provides emergency first-responders with a critical care medication to treat patients immediately at the scene of a fire or other accident as well as in a hospital emergency room.(1)

Studies have shown that cyanide, a common but often unrecognized toxic chemical found in fire smoke, may play a significant role in causing the deaths of smoke inhalation victims.(2) In the United States, smoke inhalation is responsible for up to 10,000 civilian and firefighter deaths and more than 20,000 injuries annually.(3)(4)

"It is critical that we do whatever we can to enhance the safety of Florida's first response personnel and the victims they care for in emergencies involving potential exposure to cyanide," said Dr. Joe Nelson, State EMS Medical Director. "Because cyanide poisoning acts very quickly, the immediate quick response capability that Cyanokit provides at the scene of an emergency will be critical in treating known or suspected victims of cyanide poisoning. Inclusion of Cyanokit in our EMS and fire vehicles will help protect both our emergency first responders and Florida's citizens."

"Florida's stocking of Cyanokit in its EMS and fire vehicles reflects a recognition by State officials that first responders need to be prepared to treat cyanide poisoning immediately in an emergency," said Carolyn Myers, Ph.D., President of Dey, L.P. "The ability to treat suspected cases of cyanide poisoning at the scene of a fire or other accident gives potential victims a much-needed measure of safety when survival can be measured in minutes."

About Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE(1)

Cyanokit is indicated for the treatment of known or suspected cyanide poisoning. If clinical suspicion of cyanide poisoning is high, Cyanokit should be administered without delay.

Important Safety Information

Prior to administration of Cyanokit, smoke-inhalation victims should be assessed for: exposure to fire or smoke in an enclosed area; presence of soot around the mouth, nose or oropharynx; altered mental status.

Use caution in the management of patients with known anaphylactic reactions to hydroxocobalamin or cyanocobalamin. Allergic reactions may include: anaphylaxis, chest tightness, edema, urticaria, pruritus, dyspnea, and rash.

Most common adverse reactions (>5%) are transient and include chromaturia (red-colored urine), erythema (skin redness), rash, increased blood pressure, nausea, headache, decreased lymphocyte percent, and injection site reactions. Usage may interfere with some clinical laboratory evaluations.

If the decision is made to administer another antidote with Cyanokit, these drugs should not be administered in the same IV line. The safety of simultaneous administration has not been established.

Please see full Prescribing Information at http://www.cyanokit.com or call 800-755-5560 and ask for Customer Service.

About Dey, L.P.

Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, respiratory-related allergies, and emergency care medicine. As the U.S. leader in sales of nebulized respiratory medication, Dey, L.P. puts patients first through its development of innovative and affordable therapies. The Web sites for Dey, L.P. include http://www.dey.com, http://www.accuneb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com, http://www.epipen.com and http://www.perforomist.com.

Cyanokit is a registered trademark of Merck Sante s.a.s. Cyanokit is distributed exclusively in the United States by Dey, L.P. of Napa, CA.

Media Contacts:

Dey, L.P. Media Line

800-755-5560, ext. 8363

OR

Nicole Arens

Ogilvy Public Relations Worldwide

202-729-4069

Nicole.arens@ogilvypr.com

References

1 Full Prescribing Information for Cyanokit.

2 "Report of the Investigation Committee into the Cyanide Poisonings of

Providence Firefighters," May 30, 2006.

3 "Cyanide: Understanding the Risk, Enhancing Preparedness, RTI

International," Clinical Toxicology 47-63.

4 Inna Leybell, "Toxicity, Cyanide," Emedicine from WebMD,

http://www.emedicine.com/emerg/topic118.htm (last updated May 18, 2006).


'/>"/>
SOURCE Dey, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. James Zingale Joins Safety Net Hospital Alliance of Florida
2. Registration Ends This Week: Fortune 500 Networking & Best Practice Sharing Conference in Florida
3. Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrows Leaders
4. The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity
5. Florida Hospital Group Pays U.S. $7,775,000 to Settle False Claims Act Allegations
6. David Pizzo Appointed Blue Cross and Blue Shield of Florida Market President - West Florida
7. Florida Cardiology Chooses Intergy by Sage to Integrate Practice Management and Electronic Health Records
8. Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida
9. MedeFile and Dr. Lorne Stitsky Host Open House at Personal Choice Family Practice in Jupiter, Florida
10. Blue Cross and Blue Shield of Florida Invites Floridians to Step Up to the Microphone and Talk Health Care
11. Weeping Image of Jesus at Florida Hospital Explained
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet is proud to announce the ... the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and ... 6 years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned ...
(Date:12/2/2016)... Hawaii (PRWEB) , ... December 02, 2016 , ... ... 2016 at the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering ... in the field of pain management. , The demand for supplemental training ...
(Date:12/2/2016)... ... 02, 2016 , ... Sourced from the Isbre Springs beneath the 5,000 year ... natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition to its ... available in several ShopRite and FoodTown stores in NJ and received rave comments from ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... today that it has raised $6.0 million in an initial round of funding. ... conviction that patients and their caregivers can receive far better care through the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 Persistence ... pacemaker market in its upcoming report titled, "Global Market Study on ... Declining CAGR of -1.4% between 2016 and 2024". The global ... in 2015 and this is likely to decline to ... the global cardiac pacemaker market is anticipated to exhibit ...
(Date:12/2/2016)... SPRINGFIELD GARDENS, N.Y. , Dec. 2, 2016 /PRNewswire/ ... victims, will be included in the Emergency Response Training ... "We are very excited to have LifeVac become part ... Arthur Lih , Founder and CEO of LifeVac. "Having ... use LifeVac safely and effectively will help leverage our ...
(Date:12/2/2016)... Research and Markets has announced the addition ... Demand Forecast to 2022" report to their offering. ... , , The ... and it is expected to grow at a CAGR of 5.5% during ... faster growth during the forecast period, a CAGR of 8.8% in the ...
Breaking Medicine Technology: